Influenza News and Research

Latest Influenza News and Research

Powerful mechanism helps viruses evade body's immune response

Researchers at the Salk Institute for Biological Studies have discovered a powerful mechanism by which viruses such as influenza, West Nile and Dengue evade the body's immune response and infect humans with these potentially deadly diseases. The findings may provide scientists with an attractive target for novel antiviral therapies.

19 Aug 2013

Organizations are ill prepared for e-health implementation to respond to pandemic influenza

National and international organizations are ill-prepared to exploit e-health systems in the event of the emergence of a major pandemic disease, according to a research paper to be published in the International Journal of Biomedical Engineering and Technology.

17 Aug 2013

Strategy that dismantles flu viral genome in human lung cells ensures safe research

A new strategy that dismantles a viral genome in human lung cells will ensure safe research on deadly strains of influenza, say researchers from the Icahn School of Medicine at Mount Sinai.

13 Aug 2013

GE, UW scientists to develop new medical device for detecting infectious disease

You've heard of on-demand TV, now imagine on-demand medical diagnosis - anytime, anywhere in the world. Scientists at GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are working with a team based at the University of Washington to develop a new medical device, the size of a pack of playing cards, that can detect infectious disease by way of a simple nasal swab, in less than an hour.

9 Aug 2013

Researchers unveil comprehensive portrait of the genome of world's first immortal cell line

A team from the University of Washington has unveiled a comprehensive portrait of the genome of the world's first immortal cell line, known as HeLa. The cell line was derived in 1951 from an aggressive cervical cancer that killed Henrietta Lacks, a 31-year-old African-American tobacco farmer and mother of five - the subject of the 2010 New York Times bestseller, The Immortal Life of Henrietta Lacks.

8 Aug 2013

Research shows how mammalian and bacterial kingdoms interact

The bacteria Streptococcus pneumoniae harmlessly colonizes the mucous linings of throats and noses in most people, only becoming virulent when they leave those comfortable surroundings and enter the middle ears, lungs or bloodstream. Now, in research published in July in mBio, University at Buffalo researchers reveal how that happens.

8 Aug 2013

Lupin acquires exclusive license to promote, distribute Romark's Alinia for Oral Suspension in US

Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.

7 Aug 2013

CSL Biotherapies starts shipment of seasonal influenza vaccine for 2013-2014 season

CSL Biotherapies, Inc. announced today that shipment of its seasonal influenza vaccine for the 2013-2014 season has started.

7 Aug 2013

GSK gets green light from FDA to ship Fluarix Quadrivalent influenza vaccine to healthcare providers

GlaxoSmithKline announced today it has received U.S. Food and Drug Administration approval to start shipping 2013-2014 FLUARIX QUADRIVALENT (Influenza Virus Vaccine) to CDC distribution centers and U.S. healthcare providers. This is the first season that vaccines protecting against more than three strains of influenza (flu) will be commercially available.

6 Aug 2013

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides, Inc. said it has signed a non-disclosure agreement with the Lovelace Respiratory Research Institute. The Company intends to enter into a Master Services Agreement with LRRI for the IND-enabling efficacy studies of both its broad-spectrum injectable and oral FluCide drug candidates.

5 Aug 2013

Decatur Memorial Hospital installs germ-zapping robots to kill bugs

As hospitals across the nation look for new and innovative ways to battle deadly pathogens and kill multi-drug resistant organisms that put patients at risk, Decatur Memorial Hospital (DMH) has taken a leap into the future with the installation of two germ-zapping robots that eliminate hard-to-kill bugs in hard-to-clean places.

3 Aug 2013

NCDP joins Earth Institute

The National Center for Disaster Preparedness, a research, policy and education institution that has worked for the past decade across the United States to strengthen responses to extreme weather, terrorism and other threats, has joined Columbia University's Earth Institute.

2 Aug 2013

Antibiotic prescribing rates can be reduced using internet-based training for clinicians

Antibiotic prescribing rates for acute respiratory tract infections could be significantly lowered using internet-based training for clinicians, new research has shown.

31 Jul 2013

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy

26 Jul 2013

New species of adenovirus can spread from monkey to human, say researchers

Adenoviruses commonly infect humans, causing colds, flu-like symptoms and sometimes even death, but now UC San Francisco researchers have discovered that a new species of adenovirus can spread from primate to primate, and potentially from monkey to human.

26 Jul 2013

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

Sanofi Pasteur, the vaccines division of Sanofi, announced today that the first lots of Fluzone (Influenza Virus Vaccine) for the 2013-2014 season have been released by the U.S. Food and Drug Administration for U.S. distribution and were shipped July 24.

25 Jul 2013

Discovery of pressure-driven infection mechanism opens door to new treatments for viral infections

The virus that causes those painful lip blisters known as cold sores has an internal pressure eight times higher than a car tire, and uses it to literally blast its infectious DNA into human cells, scientists are reporting in a new study.

25 Jul 2013

Inovio plans to advance synthetic hTERT cancer vaccine into clinical trials in 2014

Inovio Pharmaceuticals, Inc. announced today that in a preclinical study with two animal models, Inovio's hTERT (human telomerase reverse transcriptase) DNA cancer vaccine administered with Inovio's CELLECTRA adaptive electroporation delivery technology generated robust and broad immune responses, broke the immune system's tolerance to its self-antigens, induced T-cells with a tumor-killing function, and increased the rate of survival.

24 Jul 2013

Study helps explain why some people contract bacterial super-infections

A recent study published in the July issue of the Journal of Immunology helps explain why some humans contract bacterial super-infections like pneumonia with influenza. The research was led by Le Bonheur Pediatrician-in-Chief Jon McCullers, MD - an infectious disease specialist who is also chair of the Department of Pediatrics for the University of Tennessee Health Science Center and adjunct faculty at St. Jude Children's Research Hospital.

23 Jul 2013

BioCryst completes BCX4161 Phase 1 clinical trial for treatment of hereditary angioedema

BioCryst Pharmaceuticals, Inc. announced that the randomized, placebo-controlled, Phase 1 clinical trial of orally-administered BCX4161 in healthy volunteers successfully met all of its objectives.

22 Jul 2013

Influenza News and Research

Latest Influenza News and Research

Powerful mechanism helps viruses evade body's immune response

Organizations are ill prepared for e-health implementation to respond to pandemic influenza

Strategy that dismantles flu viral genome in human lung cells ensures safe research

GE, UW scientists to develop new medical device for detecting infectious disease

Researchers unveil comprehensive portrait of the genome of world's first immortal cell line

Research shows how mammalian and bacterial kingdoms interact

Lupin acquires exclusive license to promote, distribute Romark's Alinia for Oral Suspension in US

CSL Biotherapies starts shipment of seasonal influenza vaccine for 2013-2014 season

GSK gets green light from FDA to ship Fluarix Quadrivalent influenza vaccine to healthcare providers

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

Decatur Memorial Hospital installs germ-zapping robots to kill bugs

NCDP joins Earth Institute

Antibiotic prescribing rates can be reduced using internet-based training for clinicians

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

New species of adenovirus can spread from monkey to human, say researchers

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

Discovery of pressure-driven infection mechanism opens door to new treatments for viral infections

Inovio plans to advance synthetic hTERT cancer vaccine into clinical trials in 2014

Study helps explain why some people contract bacterial super-infections

BioCryst completes BCX4161 Phase 1 clinical trial for treatment of hereditary angioedema

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Influenza News and Research

Latest Influenza News and Research

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in